rs782623477
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_003172.4(SURF1):c.688C>T(p.Arg230*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000489 in 1,614,114 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_003172.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SURF1 | NM_003172.4 | c.688C>T | p.Arg230* | stop_gained | 7/9 | ENST00000371974.8 | NP_003163.1 | |
SURF1 | NM_001280787.1 | c.361C>T | p.Arg121* | stop_gained | 6/8 | NP_001267716.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SURF1 | ENST00000371974.8 | c.688C>T | p.Arg230* | stop_gained | 7/9 | 1 | NM_003172.4 | ENSP00000361042.3 | ||
SURF1 | ENST00000615505.4 | c.361C>T | p.Arg121* | stop_gained | 6/8 | 1 | ENSP00000482067.1 | |||
SURF1 | ENST00000437995.1 | n.598C>T | non_coding_transcript_exon_variant | 6/8 | 5 | |||||
SURF1 | ENST00000495952.5 | n.678C>T | non_coding_transcript_exon_variant | 3/5 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152224Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000111 AC: 28AN: 251462Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135920
GnomAD4 exome AF: 0.0000472 AC: 69AN: 1461890Hom.: 0 Cov.: 32 AF XY: 0.0000454 AC XY: 33AN XY: 727244
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152224Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74372
ClinVar
Submissions by phenotype
Leigh syndrome Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 24, 2020 | Variant summary: SURF1 c.688C>T (p.Arg230X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 0.00011 in 251462 control chromosomes. This frequency is not significantly higher than expected for a pathogenic variant in SURF1 causing Leigh Syndrome (0.00011 vs 0.0018). c.688C>T has been reported in the literature in multiple individuals affected with Leigh Syndrome (eg. Coenen_1999, Pieutowska-Abramczuk_2009, Wedatilake_2013, Tay_2005). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 11, 2024 | This sequence change creates a premature translational stop signal (p.Arg230*) in the SURF1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SURF1 are known to be pathogenic (PMID: 10443880, 22488715, 24027061). This variant is present in population databases (rs782623477, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with Leigh syndrome (PMID: 10558868, 10746561, 14557577, 24462369). It has also been observed to segregate with disease in related individuals. This variant is also known as c.702T>C. ClinVar contains an entry for this variant (Variation ID: 280010). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 26, 2022 | Reported previously in association with autosomal recessive Leigh syndrome due to COX deficiency (Coenen et al., 1999; Pecina et al., 2003; Wedatilake et al., 2013); Published functional studies demonstrate a damaging effect as this variant is associated with reduced COX complexes and accumulation of incomplete COX assemblies (Pecina et al., 2003); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 18583168, 25525159, 23829769, 16083427, 10558868, 12943968, 14557577, 10746561, 24462369) - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jan 25, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at